Frank Torti - Net Worth and Insider Trading
Frank Torti Net Worth
The estimated net worth of Frank Torti is at least $11 Million dollars as of 2024-09-21. Frank Torti is the Director of Immunovant Inc and owns about 393,358 shares of Immunovant Inc (IMVT) stock worth over $11 Million. Details can be seen in Frank Torti's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frank Torti has not made any transactions after 2022-09-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frank Torti
Frank Torti Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank Torti owns 6 companies in total, including Arbutus Biopharma Corp (ABUS) , Immunovant Inc (IMVTU) , and Sio Gene Therapies Inc (SIOX) among others .
Click here to see the complete history of Frank Torti’s form 4 insider trades.
Insider Ownership Summary of Frank Torti
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2018-11-26 | director |
| IMVTU | Immunovant Inc | 2020-05-15 | director |
| SIOX | Sio Gene Therapies Inc | 2018-09-26 | director |
 | | 2018-11-06 | director |
| | 2019-07-09 | director |
| | 2022-09-29 | director |
Frank Torti Latest Holdings Summary
Frank Torti currently owns a total of 1 stock. Frank Torti owns 393,358 shares of Immunovant Inc (IMVT) as of September 29, 2022, with a value of $11 Million.
Latest Holdings of Frank Torti
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMVT | Immunovant Inc | 2022-09-29 | 393,358 | 29.24 | 11,499,821 |
Holding Weightings of Frank Torti
Frank Torti Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank Torti has made a total of 1 transactions in Immunovant Inc (IMVT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immunovant Inc is the acquisition of 20,000 shares on September 29, 2022, which cost Frank Torti around $116,200.
Insider Trading History of Frank Torti
- 1
Frank Torti Trading Performance
GuruFocus tracks the stock performance after each of Frank Torti's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank Torti is 223.61%. GuruFocus also compares Frank Torti's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank Torti within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frank Torti's insider trading performs compared to the benchmark.
Performance of Frank Torti
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 105.58 | | | | | |
| Relative Return to S&P 500(%) | 98.42 | | | | | |
Frank Torti Ownership Network
Frank Torti Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Frank Torti is the director of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Frank Torti made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Frank Torti Mailing Address
Above is the net worth, insider trading, and ownership report for Frank Torti. You might contact Frank Torti via mailing address: 2855 Sand Hill Road, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
